Amoy Diagnostics AmoyDx Pan Lung Cancer PCR Panel

Amoy Diagnostics and Premia have launched the AmoyDx Pan Lung Cancer PCR Panel in Japan as a reimbursed companion diagnostic for multiple anti-cancer agents. The panel was conceived by AmoyDx, who also manufactures it, and developed in Japan by Premia. It uses real-time PCR to evaluate 11 driver genes. In Japan, the use of five driver genes on the panel has been approved as a companion diagnostic for 10 targeted therapies for non-small cell lung cancer.